GRAIL (GRAL) Stock: Buy, Sell, or Hold?
$124.74
-3.34 (-2.61%)
▼
5d:
-10.54%
30d:
-9.19%
90d:
+65.26%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (77%)
Quality Score
60/100
Position
OVERSOLD
30-Day Fair Range
$127.30 – $147.13
Position: OVERSOLD
Forward P/E & Valuation
-15.6x
Next 12M consensus est.
Wall Street Target
$132.11
+5.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$117.00 / $161.90
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: GRAL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $124.74, which is considered oversold relative to its 30-day fair value range of $127.30 to $147.13.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $117.00, while resistance sits at $161.90.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $117.00, while resistance sits at $161.90.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$127.30 -
$147.13
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$127.30 -
$147.13
Current vs Trading Range
OVERSOLD
Support Level
$117.00
Resistance Level
$161.90
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding GRAL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($132.11)
- NEUTRAL: Bottoming setup forming (56/100) — watch for confirmation
- CAUTION: 5-day price weakness (-10.5%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-15.62
Wall Street Target
$132.11
(+5.9%)
Revenue Growth (YoY)
3.7%
Profit Margin
-243.8%
Share GRAL Analysis
Share this live GRAL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GRAL)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Grail reported Q3 revenue missing estimates despite a favorable FDA vote for its cancer-detecting test, leading to a significant stock price decline.
Key Retail Themes:
Earnings miss and stock price decline
FDA vote for Galleri multi-cancer early detection test
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 58 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 56 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GRAL Research Pages
